AGL — Agilon Health Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.45bn
- $1.08bn
- $4.32bn
- 28
- 59
- 29
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -283 | -60.1 | -407 | -107 | -263 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 120 | -10.9 | 302 | 21.2 | 96.5 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 33.2 | 6.47 | -55 | -59.4 | -10.1 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -104 | -53.2 | -148 | -131 | -156 |
Capital Expenditures | -3.91 | -2.35 | -13.4 | -32.7 | -30.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.15 | 24.4 | -77.1 | -412 | -13.2 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.06 | 22.1 | -90.5 | -444 | -44 |
Financing Cash Flow Items | -0.303 | 0 | -14.7 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 176 | 24.6 | 1,154 | 28.1 | -193 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 67.4 | -6.52 | 916 | -547 | -393 |